EMR vs FORM vs IEX Stock Comparison

Emerson Electric, Formfactor and Idex Prices as of Nov 13, 2026 Peers: Industry group
EMR Emerson Electric Co
$166.41 +3.3% 1M +29.5% 1Y
Market cap
$90.24B
P/E
33.5x
Revenue (TTM)
$18.98B
Div. yield
0.01%
Pumps and Valves Industrials
3 wins
FORM Formfactor Inc
$87.53 -26.9% 1M +72.6% 1Y
Market cap
$6.47B
P/E
37.3x
Revenue (TTM)
$980.10M
Div. yield
–
Test and Measurement Technology
7 wins
IEX Idex Corp /De/
$237.63 -0.5% 1M +42.2% 1Y
Market cap
$17.27B
P/E
32.2x
Revenue (TTM)
$3.66B
Div. yield
0.01%
Pumps and Valves Industrials
2 wins

Head to Head

12 decided of 12

Formfactor leads on 7 of the 12 questions below (Formfactor 7, Emerson Electric 3, Idex 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionEMRFORMIEXLeader
Larger companyMarket capitalisation $90.24B $6.47B $17.27B EMR
Cheaper on earningsLower P/E, profitable companies only 33.5x 37.3x 32.2x IEX
Cheaper on forward earningsLower price / next fiscal year consensus EPS 21.4x 25.1x 25.7x EMR
Faster revenue growthRevenue growth, trailing twelve months +5.4% +29.1% +6.9% FORM
More profitableNet margin, trailing twelve months 14.2% 17.7% 14.6% FORM
Better return on capitalReturn on invested capital 11.2% 13.6% 10.0% FORM
Less leveragedLower net debt / EBITDA 1.6x -1.8x 1.2x FORM
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.01% EMR
Better 1-year returnPrice return, last 12 months +29.5% +72.6% +42.2% FORM
Better 5-year returnAnnualised price return, 5 years +11.3%/yr +15.4%/yr +0.2%/yr FORM
Less volatileAnnualised volatility, 1 year 32.1% 89.4% 22.9% IEX
Higher overall scoreMean of the five percentile scores vs peers 49/100 72/100 55/100 FORM

Percentile Scorecard

EMRFORMIEX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisEMRFORMIEX
Valuation 34 #140 of 210 42 #68 of 116 35 #137 of 210
Growth 45 #108 of 196 96 #5 of 110 41 #116 of 196
Profitability 88 #25 of 197 87 #15 of 108 85 #30 of 197
Financial Health 37 #142 of 223 91 #12 of 121 78 #51 of 223
Shareholder Returns 43 #93 of 162 46 #46 of 84 37 #103 of 162
Overall 49 72 55
  • EMR ranked among 225 companies in Machinery
  • FORM ranked among 122 companies in Computer Hardware
  • IEX ranked among 225 companies in Machinery

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodEMRFORMIEXSPY
1 month +3.3%-26.9%-0.5% -2.0%
3 months +2.0%-33.5%-0.5% -2.8%
6 months +25.1%-30.7%+14.4% +2.0%
Year to date +25.4%+56.9%+33.5% +10.6%
1 year +29.5%+72.6%+42.2% +12.2%
3 years +87.9%+124.6%+20.0% +68.1%
3 years, per year +23.4%+31.0%+6.3% +18.9%
5 years +70.8%+105.0%+1.1% +61.4%
5 years, per year +11.3%+15.4%+0.2% +10.1%
10 years +199.8%+758.1%+156.9% +248.5%
10 years, per year +11.6%+24.0%+9.9% +13.3%

Risk

MeasureEMRFORMIEXSPY
Volatility, 1Y 32.1%89.4%22.9% 13.6%
Downside volatility, 1Y 33.5%95.7%21.1% 13.9%
Beta vs S&P 500, 1Y 1.513.270.75 1.00
Return / volatility, 1Y 0.920.811.84 0.90
Max drawdown, 5Y -29.9%-62.7%-35.9% -25.4%
From 52-week high -2.5%-45.3%-1.2% -3.2%
52-week high $170.76$159.93$240.52 $779.14
52-week low $123.30$48.68$161.68 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleEMRFORMIEX
P/E now vs peer median 34.6xmedian 24.6x 39.5xmedian 26.9x 32.7xmedian 24.6x
P/S now vs peer median 4.9xmedian 1.8x 7.0xmedian 2.2x 4.8xmedian 1.8x
EV/EBITDA now vs peer median 16.3xmedian 13.7x 30.0xmedian 15.5x 19.0xmedian 13.7x
P/FCF now vs peer median 26.2xmedian 21.9x 37.9xmedian 21.4x 26.2xmedian 21.9x
P/B now vs peer median 4.5xmedian 2.2x 5.8xmedian 2.4x 4.3xmedian 2.2x
PEG now vs peer median -0.85median 1.08 0.20median 1.03 -8.58median 1.08

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsEMRFORMIEX
Revenue $18.98B $980.10M $3.66B
Gross profit $10.13B $461.88M $1.64B
Operating income $4.83B $179.53M $763.90M
Net income $2.69B $173.63M $535.80M
Free cash flow $3.54B $181.26M $667.10M
R&D – $121.79M –
EPS (diluted) $4.79 $2.19 $7.24
Cash & equivalents $1.81B $138.18M $602.10M
Total debt $12.18B $11.36M $1.75B
Shares (diluted) 562.00M 79.45M 74.00M
Enterprise value $82.72B $5.15B $14.88B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricEMRFORMIEX
P/E 34.6x 39.5x 32.7x
P/FCF 26.2x 37.9x 26.2x
P/Operating cash flow 23.3x 26.7x 23.2x
P/S 4.9x 7.0x 4.8x
P/B 4.5x 5.8x 4.3x
P/Tangible book 7.5x 5.9x 6.0x
EV/EBITDA 16.3x 30.0x 19.0x
EV/EBIT 21.3x 36.1x 24.4x
EV/Revenue 5.4x 6.6x 5.1x
EV/FCF 29.2x 35.7x 27.9x
EV/Operating cash flow 25.9x 25.2x 24.7x
PEG (3Y EPS CAGR) -0.85 0.20 -8.58

Growth

14 metrics
MetricEMRFORMIEX
Revenue growth (1Y) 5.4% 29.1% 6.9%
Revenue CAGR (3Y) 7.8% 14.0% 3.5%
Gross profit growth (1Y) 6.4% 58.4% 8.1%
Gross profit CAGR (3Y) 10.9% 25.1% 4.1%
Operating income growth (1Y) 9.5% 333.3% 12.2%
Operating income CAGR (3Y) 14.2% 143.4% 0.7%
Net income growth (1Y) 18.6% 325.1% 12.1%
Net income CAGR (3Y) -41.2% 196.9% -4.6%
EPS growth (1Y) 19.6% 315.9% 13.9%
EPS CAGR (3Y) -40.6% 195.7% -3.8%
Operating cash flow growth (1Y) 8.2% 144.0% 17.0%
Operating cash flow CAGR (3Y) 13.6% 50.0% 3.3%
Free cash flow growth (1Y) 8.9% 3,302% 14.2%
Free cash flow CAGR (3Y) 14.6% 263.8% 3.9%

Profitability

14 metrics
MetricEMRFORMIEX
Gross margin 53.4% 47.1% 44.9%
EBITDA margin 33.2% 22.0% 26.7%
Operating margin 25.5% 18.3% 20.9%
Pretax margin 18.4% 19.5% 19.2%
Net margin 14.2% 17.7% 14.6%
FCF margin 18.6% 18.5% 18.2%
Operating cash flow margin 21.0% 26.2% 20.6%
Return on equity 13.1% 14.6% 13.4%
Return on assets 6.4% 12.1% 7.8%
Return on invested capital 11.2% 13.6% 10.0%
Return on capital employed 15.2% 15.1% 12.2%
Asset turnover 0.5x 0.7x 0.5x
Cash conversion (OCF / net income) 1.5x 1.5x 1.4x
Stock comp / revenue 1.2% 3.6% 0.9%

Financial Health

11 metrics
MetricEMRFORMIEX
Debt / assets 29.1% 0.8% 25.5%
Debt / equity 0.6x 0.0x 0.4x
Net debt / EBITDA 1.6x -1.8x 1.2x
Debt / FCF 3.4x 0.1x 2.6x
Liabilities / assets 50.4% 17.5% 41.6%
Equity / assets 49.6% 82.5% 58.4%
Interest coverage – – –
Current ratio 0.9x 3.7x 2.8x
Quick ratio 0.6x 2.8x 1.8x
Cash ratio 0.2x 2.0x 0.9x
Altman Z-score 4.86 18.30 5.72

Shareholder Returns

7 metrics
MetricEMRFORMIEX
Dividend yield 1.7% – 1.2%
Net buyback yield 1.1% -0.2% 1.6%
Shareholder yield 2.8% -0.2% 2.8%
Payout ratio (earnings) 46.2% – 39.9%
Payout ratio (FCF) 35.2% – 32.1%
Dividend growth (1Y) 4.4% – 1.0%
Dividend CAGR (3Y) 1.3% – 4.5%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusEMRFORMIEX
Forward P/E 21.4xFY2027 25.1xFY2026 25.7xFY2026
EPS, next fiscal year $7.78FY2027 $3.49FY2026 $9.25FY2026
EPS growth, next FY +18.1%FY2027 +168.5%FY2026 +16.4%FY2026
EPS growth, the year after +6.9% +33.8% +12.4%
Revenue, next fiscal year $20.95BFY2027 $1.00BFY2026 $3.96BFY2026
Revenue growth, next FY +10.4%FY2027 +27.6%FY2026 +14.6%FY2026
Revenue growth, the year after +6.8% +28.0% +2.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersEMRFORMIEX
Held by institutions 82.1% 92.0% 100.0%
Institutions holding 2,294 511 689
Change in shares held, QoQ +0.9% -3.7% +0.1%
Institutions buying 1,083 303 353
Institutions selling 799 170 202
Buyers to sellers 1.36 1.78 1.75

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

EMRFORMIEX
EMR 1.00 0.38 0.65
FORM 0.38 1.00 0.42
IEX 0.65 0.42 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, EMR, FORM and IEX?

Emerson Electric (EMR) is the largest by market capitalisation: Emerson Electric (EMR) $90.24B, Formfactor (FORM) $6.47B, Idex (IEX) $17.27B.

Which stock is cheaper, EMR, FORM and IEX?

Idex (IEX) trades on the lowest price-to-earnings ratio (Emerson Electric (EMR) 33.5x, Formfactor (FORM) 37.3x, Idex (IEX) 32.2x). On next year's consensus earnings, Emerson Electric (EMR) is cheapest (Emerson Electric (EMR) 21.4x, Formfactor (FORM) 25.1x, Idex (IEX) 25.7x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Formfactor (FORM) grew revenue fastest over the trailing twelve months: Emerson Electric (EMR) +5.4%, Formfactor (FORM) +29.1%, Idex (IEX) +6.9%.

Which company is more profitable?

Formfactor (FORM) has the highest net margin (Emerson Electric (EMR) 14.2%, Formfactor (FORM) 17.7%, Idex (IEX) 14.6%). On return on invested capital, Formfactor (FORM) leads (Emerson Electric (EMR) 11.2%, Formfactor (FORM) 13.6%, Idex (IEX) 10.0%).

Which stock has performed better?

Over the past year Formfactor (FORM) returned the most: Emerson Electric (EMR) +29.5%, Formfactor (FORM) +72.6%, Idex (IEX) +42.2%. Over five years, Formfactor (FORM) compounded fastest (Emerson Electric (EMR) +11.3%/yr, Formfactor (FORM) +15.4%/yr, Idex (IEX) +0.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Emerson Electric (EMR) has the highest dividend yield: Emerson Electric (EMR) 0.01%, Formfactor (FORM) 0.00%, Idex (IEX) 0.01%. Formfactor (FORM) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Idex (IEX) has been the steadiest (Emerson Electric (EMR) 32.1%, Formfactor (FORM) 89.4%, Idex (IEX) 22.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, EMR, FORM and IEX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Formfactor (FORM) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.